Flynn James E
SEC insider (Form 3/4/5 filer). CIK 0001352546. Director & 10% Owner at Nuvalent, Inc. (NUVL) and 6 other issuers. 56 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in NEW YORK, NY.
Companies Flynn James E has filed insider reports for
- Nuvalent, Inc. (NUVL): Director, 10% Owner
- Parabilis Medicines, Inc. (PBLS): 10% Owner
- Larimar Therapeutics, Inc. (LRMR): Director, 10% Owner
- ARS Pharmaceuticals, Inc. (SPRY): 10% Owner
- BiomX Inc. (PHGE): Director
- Acutus Medical, Inc. (AFIB): Director
- Bicara Therapeutics Inc. (BCAX): 10% Owner
Flynn James E
CIK: 0001352546
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (56 total)
- Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionIndirect3.4K shares at avg. $124.00$427K - Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionIndirect8.3M shares at avg. $124.00$1.0B - Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionIndirect650K shares at avg. $124.00$80.6M - Jul 15, 2026NUVL
Nuvalent, Inc.
Tender OfferIndirect5.1K shares at avg. $124.00$638K - Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionIndirect8.3M shares at avg. $124.00$1.0B - Jul 15, 2026NUVL
Nuvalent, Inc.
Tender OfferIndirect5.1K shares at avg. $124.00$638K - Jun 16, 2026NUVL
Nuvalent, Inc.
AwardIndirect3.4K shares- - Jun 11, 2026PBLS
Parabilis Medicines, Inc.
ConversionIndirect407.1K shares- - Jun 11, 2026PBLS
Parabilis Medicines, Inc.
ConversionIndirect261K shares- - Jun 11, 2026PBLS
Parabilis Medicines, Inc.
ConversionIndirect149.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  NUVL Nuvalent, Inc. | Disposition | 3,444 | $124.00 | $427,056 | Indirect |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Disposition | 8,299,225 | $124.00 | $1,029,103,900 | Indirect |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Disposition | 650,000 | $124.00 | $80,600,000 | Indirect |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Tender Offer | 5,146 | $124.00 | $638,104 | Indirect |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Disposition | 8,299,225 | $124.00 | $1,029,103,900 | Indirect |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Tender Offer | 5,146 | $124.00 | $638,104 | Indirect |
| Jun 16, 2026 | NUVL Nuvalent, Inc. | Award | 3,444 | - | $0 | Indirect |
| Jun 11, 2026 |  PBLS Parabilis Medicines, Inc. | Conversion | 407,132 | - | $0 | Indirect |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc. | Conversion | 260,992 | - | $0 | Indirect |
| Jun 11, 2026 | PBLS Parabilis Medicines, Inc. | Conversion | 149,238 | - | $0 | Indirect |
1-10 of 56 transactions